Outlook Therapeutics Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Outlook Therapeutics Inc's ROI in the third quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Outlook Therapeutics Inc 's return on investment (ROI) in its third quarter of 2026

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) III. Quarter	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-2	-17	-27	2	-9
Return On Investment (TTM)	-	-	-	947.06 %	-
OTLK's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-61	-61	-103	-62	-43

OTLK Company Profile >> Back to OTLK Roi Comparisons >> See Annual OTLK Return On Investment

Return On Investment OTLK's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Outlook Therapeutics Inc's III. Quarter Investments	$ -2 Millions	OTLK's Balance sheet
Outlook Therapeutics Inc's III. Quarter Income	$ -20 Millions	Quarterly OTLK's Income Statement
OTLK's Income by Division		See OTLK's Income by Division

OTLK Annual Return On Investment	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023	(Sep 30 2022) 2022	(Sep 30 2021) 2021
Total Investments in Millions	-27	-14	-14	9	16
Y / Y Investment Growth	-	-	-	-45.22 %	317.8 %
Net Income in Millions	-62	-75	-59	-66	-53
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-750.77 %	-331.05 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OTLK's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OTLK's Competitors
Subscribers only: Roi for Outlook Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for OTLK's Customers

Other Ratios
OTLK's Roa	OTLK's Inventory Turnover Ratio	OTLK's Growth Rates	OTLK's Dividend Statistics
	OTLK's Profitability Ratios	OTLK's Asset Turnover Ratio	OTLK's Dividend Growth
OTLK's Roe	OTLK's Valuation Ratios	OTLK's Financial Strength Ratios	OTLK's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Glucotrack Inc	843.28 %
Stablecoin Development Corporation	618.18 %
Omeros Corporation	198.34 %
Elutia Inc	191.75 %
Sanuwave Health Inc	167.92 %
Vor Biopharma Inc	162.71 %
Capforce Inc	161.42 %
Kyntra Bio Inc	157.74 %
Silexion Therapeutics Corp	127.60 %
Quince Therapeutics Inc	112.49 %

Date modified: 2026-08-29T17:35:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.